Ergomed PLC (AIM: ERGO) – Positive financial results and a good start to 2015
In July 2014 Ergomed listed on AIM raising £11m at IPO. They acquired PrimeVigilance at IPO for £6m in cash and £3m in shares. PrimeVigilance is a post-marketing pharmacovigilance and medical information business that works with pharmaceutical, generic and biotech companies assisting them in managing the global safety of their pharmaceutical drug products and late stage drug developments. It complements Ergomed’s existing business.
Ergomed provides clinical development, trial…
Sign up and read the full article
Register to continue reading our content.
Already a member? Login
Previous article Next article